SUPPLEMENTARY MATERIAL 1 2
Studying the regression profiles of 3 cervical tumours during radiotherapy 4 treatment using a patient-specific 5 multiscale model. t is the duration of each pulse, 56
x is the time between pulses without irradiation, 57 μ is the repair rate constant, 58 and T 1/2 is the half time for sub-lethal damage repair. Monoexponential recovery kinetics is assumed. 59
60
In order to simulate within CERONCO, where a time step of one hour is used, the number of cells that 61 are lethally hit by each successive pulse the following consideration has been made: 62
Let P init be the initial tumour cell population. According to the modified LQ model, after N pulses of 63 dose d have been applied the remaining (survived) tumour cell population will be: 64
The number of surviving tumour cells just after each successive pulse in the N-pulse scheme is given 66 Since each pulse acts upon the tumour cell population that remained alive after all previous pulses the 74 following equation applies for every two successive pulses: 75
…, N (S8) 76
Where SF i is the survival fraction after the i-th pulse of the N-pulse scheme. 77
The goal is to derive a suitable mathematical formulation of SF i , so that the correct number of lethally 78 hit cells is computed within CERONCO at the appropriate time points, just after each pulse dose. 79 In the pulsed brachytherapy scheme considered in the context of this study two brachytherapy 97 fractions of 20 pulses each are used. The pulse dose is derived for each geometrical cell of the tumour 98 mesh from the corresponding total dose distribution raw file by dividing the total dose corresponding 99 to the specific geometrical cell by the number of pulses. The interval between successive pulses is 1 100 2) BT1, BT2 spatial dose distribution raw files (dose per GC). 167
These 3D-reconstruction raw files supply the model with the tumour's spatial information and 168 correspond to the region of interest onto which the discretizing mesh of the model is superimposed. 169
Within each raw file each Geometrical Cell (GC) of the mesh is labeled as tumour or non/tumour. The 170 procedure for the creation of these input files is the following: 171
• A Reference CT is acquired prior to therapy 172
• A Reference GTV is derived from the reference CT 173
• The MRI images of all available time points (pretherapy, mid-term, BT0, BT1, BT2) are 174 registered to the reference CT. 175
• GTV files are derived from each MRI 176
• The MRI GTV files are registered to the Reference GTV (registration to the Reference GTV 177 center of mass) 178
• The same procedure is used to produce the raw files for the BT doses 179 180 T2 weighted MRI with 4mm slice thickness was acquired according to the GEC ESTRO guidelines 181 ), unless more specific information for a particular tumour is available.
DF (%)
Initial tumour dead fraction (Percentage of dead tumour cells over all tumour cells).
Defined by the user.
In the current study its estimation was based on the provided initial tumour's necrotic diameter. 
Necrosis rate of differentiated cells (fraction of differentiated cells dying through necrosis per hour)
Fraction of stem and LIMP cells entering G0 phase after mitosis 
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10%, HF 30%, DF 5%, the simulations do not retrieve any solutions under the volumetric criteria studied.
230
These tumours seem to be incompatible with these specific tumour profiles.
232
TUMOUR PROFILE GF=60% HF=30% DF=5% For patient 71 and tumour profile GF 60%, HF 30%, DF 5%, as well as for patient 88 and the tumour profile GF 10%, HF 30%, DF 5%, the simulations do not retrieve any solutions under the volumetric criteria studied. These tumours seem to be incompatible with these specific tumour profiles. 
